William H. Milmoe - Nov 3, 2021 Form 4 Insider Report for INTEGRATED BIOPHARMA INC (INBP)

Role
Director, 10%+ Owner
Signature
/s/ William H. Milmoe
Stock symbol
INBP
Transactions as of
Nov 3, 2021
Transactions value $
$0
Form type
4
Date filed
11/4/2021, 12:22 PM
Previous filing
Jun 15, 2021
Next filing
Dec 2, 2021

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction INBP Stock Option (right to buy) Award $0 +50K $0.00 50K Nov 3, 2021 Common Stock 50K Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The Exercise Price of the Stock Option will be the closing price of the Issuer's Common Stock five trading days after the filing of the Issuer's Quarterly Report on Form 10-Q for the period ended September 30, 2021, with the Securities and Exchange Commission(the "Issue Date").
F2 The option vests and becomes exercisable as follows: 25% (12,500 shares) on the Issue Date, 25% (12,500 shares) on December 31, 2021, 25% (12,500 shares) on March 31, 2022 and 25% (12,500 shares) on June 30, 2022.